Product NDC: | 63323-355 |
Proprietary Name: | Levofloxacin |
Non Proprietary Name: | LEVOFLOXACIN |
Active Ingredient(s): | 5 mg/mL & nbsp; LEVOFLOXACIN |
Administration Route(s): | INTRAVENOUS |
Dosage Form(s): | INJECTION |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 63323-355 |
Labeler Name: | Fresenius Kabi USA, LLC |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA200674 |
Marketing Category: | ANDA |
Start Marketing Date: | 20130620 |
Package NDC: | 63323-355-60 |
Package Description: | 1 BAG in 1 POUCH (63323-355-60) > 150 mL in 1 BAG |
NDC Code | 63323-355-60 |
Proprietary Name | Levofloxacin |
Package Description | 1 BAG in 1 POUCH (63323-355-60) > 150 mL in 1 BAG |
Product NDC | 63323-355 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | LEVOFLOXACIN |
Dosage Form Name | INJECTION |
Route Name | INTRAVENOUS |
Start Marketing Date | 20130620 |
Marketing Category Name | ANDA |
Labeler Name | Fresenius Kabi USA, LLC |
Substance Name | LEVOFLOXACIN |
Strength Number | 5 |
Strength Unit | mg/mL |
Pharmaceutical Classes |